Purple Sales General And Administrative To Revenue from 2010 to 2024

PPBT Stock  USD 4.11  0.17  3.97%   
Purple Biotech Sales General And Administrative To Revenue yearly trend continues to be comparatively stable with very little volatility. Sales General And Administrative To Revenue will likely drop to 6.63 in 2024. From the period from 2010 to 2024, Purple Biotech Sales General And Administrative To Revenue quarterly data regression had r-value of (0.86) and coefficient of variation of  80.96. View All Fundamentals
 
Sales General And Administrative To Revenue  
First Reported
2010-12-31
Previous Quarter
6.98
Current Value
6.63
Quarterly Volatility
29.86755508
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Purple Biotech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Purple Biotech's main balance sheet or income statement drivers, such as Depreciation And Amortization of 208.9 K, Interest Expense of 2.3 M or Selling General Administrative of 4.6 M, as well as many indicators such as Price To Sales Ratio of 84.89, Dividend Yield of 0.088 or PTB Ratio of 0.49. Purple financial statements analysis is a perfect complement when working with Purple Biotech Valuation or Volatility modules.
  
Check out the analysis of Purple Biotech Correlation against competitors.
For more information on how to buy Purple Stock please use our How to Invest in Purple Biotech guide.

Latest Purple Biotech's Sales General And Administrative To Revenue Growth Pattern

Below is the plot of the Sales General And Administrative To Revenue of Purple Biotech over the last few years. It is Purple Biotech's Sales General And Administrative To Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Purple Biotech's overall financial position and show how it may be relating to other accounts over time.
Sales General And Administrative To Revenue10 Years Trend
Slightly volatile
   Sales General And Administrative To Revenue   
       Timeline  

Purple Sales General And Administrative To Revenue Regression Statistics

Arithmetic Mean36.89
Geometric Mean21.18
Coefficient Of Variation80.96
Mean Deviation28.79
Median63.88
Standard Deviation29.87
Sample Variance892.07
Range59.428
R-Value(0.86)
Mean Square Error247.79
R-Squared0.74
Significance0.000037
Slope(5.75)
Total Sum of Squares12,489

Purple Sales General And Administrative To Revenue History

2024 6.63
2023 6.98
2020 6.07
2019 6.08
2018 4.45

About Purple Biotech Financial Statements

Purple Biotech shareholders use historical fundamental indicators, such as Sales General And Administrative To Revenue, to determine how well the company is positioned to perform in the future. Although Purple Biotech investors may analyze each financial statement separately, they are all interrelated. The changes in Purple Biotech's assets and liabilities, for example, are also reflected in the revenues and expenses on on Purple Biotech's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Sales General And Administrative To Revenue 6.98  6.63 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Purple Stock Analysis

When running Purple Biotech's price analysis, check to measure Purple Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Purple Biotech is operating at the current time. Most of Purple Biotech's value examination focuses on studying past and present price action to predict the probability of Purple Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Purple Biotech's price. Additionally, you may evaluate how the addition of Purple Biotech to your portfolios can decrease your overall portfolio volatility.